Janeen Doyle
About Janeen Doyle
Janeen Doyle is the Senior Vice President of Strategy Business Development at Bristol Myers Squibb, with over 20 years of experience in the biopharmaceutical industry.
Title
Janeen Doyle is currently serving as the Senior Vice President of Strategy Business Development at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
In her current role, Janeen Doyle is responsible for leading the Strategy Business Development efforts at Bristol Myers Squibb. This involves overseeing strategic initiatives, managing business development activities, and fostering growth opportunities aligned with corporate goals.
Previous Roles at Bristol Myers Squibb
Janeen Doyle has an extensive history at Bristol Myers Squibb, having previously served as the Vice President of Business Development & Global Alliances, Research & Early Development. During her three-year tenure from 2019 to 2022, she played a pivotal role in advancing the company's research and early development strategies.
Experience at Celgene
Before joining Bristol Myers Squibb, Janeen Doyle held multiple positions at Celgene. She was the Executive Director of Business Development & Global Alliances from 2016 to 2019, Director of Global Program Leadership from 2013 to 2016, and Associate Director of Global Medical Affairs from 2009 to 2013. Her work at Celgene spanned various functional areas including program leadership and medical affairs.
Career Beginnings and Other Roles
Janeen Doyle began her career in the biopharmaceutical industry at Altana Pharma, where she worked as a Clinical Trial Associate and later as a Clinical Research Associate from 2001 to 2007. She then moved to Regeneron Pharmaceuticals as a Clinical Science Manager, Clinical Development, from 2007 to 2009. Her early career also included a brief stint at Schering-Plough Pharmaceuticals as a Clinical Specialist in 2000.
Education and Academic Background
Janeen Doyle holds a Bachelor of Science (B.S.) in Biology from Moravian University and a Master of Business Administration (M.B.A.) in Business Administration and Management, General, from the University of Scranton. Her educational background has provided her with a solid foundation in both the scientific and business aspects of the biopharmaceutical industry.
Biopharmaceutical Industry Experience
With over 20 years of experience in the biopharmaceutical industry, Janeen Doyle has covered a wide range of functional areas, including business development, strategy, program leadership, medical affairs, clinical science, and clinical operations. Her experience spans large pharmaceutical companies, mid-size biotech firms, and small high-growth environments.